XCOPRI | Epilepsy Talk

How are your meds affecting you?

March 10, 2023
4 Comments

They’re necessary, but not necessarily nice. And every med has its own side-effects. Just as different people experience different difficulties.

Here‘s the low-down on the possible side-effects of your drugs and the secrets they may hold.

Some might sound painfully familiar…

Posted in Epilepsy, Medication Issues, Research
Tags: anti-epilepsy drug side-effects, Ativan, Banzel, Briviact, Carbatrol, Depakote and Depakene, Diamox, Diastat Acudial, Dilantin, Felbatol, Gabitril, Hp Acthar Gel, Kepppra, Klonopin, Lamictal, Lyrica, Mysoline, Neurontin, Onfi, Peganone, Perampanel, Phenobarbital, Phenytek, Portiga, Rufinamide, Sabril, Tegretol, Topamax, Tranxene, Trileptal, Viibryd, Vimpat, XCOPRI, Zarontin, Zonegran

Xcopri provides long-term seizure control in patients with focal epilepsy

June 26, 2022
Leave a Comment

Long-term use of Xcopri was safe and reduced seizures by more than 90% in adults with uncontrolled focal seizures, according to results of an open-label extension study published in Neurology.

Posted in Epilepsy, Medication Issues, News, Research
Tags: breakthrough, long-term seizure control, XCOPRI

Good news, there’s a new AED in town!

December 4, 2019
68 Comments

On November 19, 2019, the U.S. Food and Drug Administration approved cenobamate (XCOPRI®) for the treatment of focal epilepsy in adults. This medication will be available in the pharmacy by the spring or summer of 2020.

Posted in Epilepsy, Medication Issues, News, Research
Tags: focal epilepsy, lower seizure frequency, new drug, XCOPRI

Epilepsy Talk

How are your meds affecting you?

Xcopri provides long-term seizure control in patients with focal epilepsy

Good news, there’s a new AED in town!

Phylis Feiner Johnson